According to epidemiologists, the Indian variant of the corona virus can spread rapidly similar to UK variant. However, so far there has been little evidence that it is more deadly than the original virus.
SARS-COV2’s B1.617 Found More in Maharashtra and Delhi
The B1.617 variant of SARS-COV2 is the double mutant or the Indian strain of corona. Maharashtra and Delhi have reported most cases of this strain in the second wave of pandemic in India.
Corona virus cases have increased significantly in Delhi and Maharashtra in the last few weeks as the healthcare system collapsed. There is a severe shortage of medical oxygen in many hospitals in Delhi.
Study of Many Symptoms Remains: Dr. Aggarwal
Anurag Aggarwal is the director of the Institute of Genomics and Integrative Biology (IGIB). He said, ‘As far as we know, it is neither associated with the British variant nor with the increasing severity of disease or death. Meanwhile, the studies have proven that the British form spreads rapidly. Yet, it is possible that the B1.617 variant may spread more rapidly, but it has not been proven. Study of many traits of the new strain is not yet complete.
IGIB is one of 10 laboratories across the country that is doing genome sequencing of viruses. He, however, said that there is no comparison as to which virus has increased proliferation capacity. Dr Agarwal said that considering the experience of Maharashtra, this form seems to be spreading rapidly, but research is yet to prove it. He said that given the general evidence, this form (B.1.617) can spread more rapidly.
The More Infected, The More the Deaths
Asked about more deaths in the state this time than in the first wave of last year, Aggarwal said that it has a direct relation with how much the nature can spread and the more patients will be infected, the higher the number of dead.
NCBS said – No Reports of Fatalities
Saumitra Das, director of the National Center for Biological Sciences (NCBS). He said that there is no report of fatality related to the B.1.617 form. The NCBS is located in Kalyani, West Bengal. It is one of the 10 organizations doing genome sequencing of the corona virus. Das said in a webinar last week that the vaccines available in various forms found in India are effective.